# Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse

> **NCT01092624** · PHASE4 · TERMINATED · sponsor: **Hartford Hospital** · enrollment: 94 (estimated)

## Conditions studied

- Pelvic Organ Prolapse

## Interventions

- **DRUG:** Solifenacin
- **DRUG:** Placebo
- **DEVICE:** Ring pessary with support, Cooper Surgical, Trumbell, CT Ref # MXPRS03 non-latex

## Key facts

- **NCT ID:** NCT01092624
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-03
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 94 (ESTIMATED)
- **Why stopped:** sponsor closed study due to poor enrollment
- **Last updated:** 2011-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092624, "Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01092624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*